Glaukos (GKOS) Assets Average (2015 - 2026)
Glaukos' (GKOS) quarterly Assets Average came in at $906.9 million in Q2 2026, down 7.13% year-over-year from $976.6 million in Q2 2025, and up 1.51% quarter-over-quarter from $893.4 million in Q1 2026.
Analysis
Glaukos (GKOS) Assets Average (2015 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Assets Average for 12 consecutive years, with $906.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average fell 7.13% year-over-year to $906.9 million in Q2 2026; TTM through Jun 2026 was $906.9 million, a 7.13% decrease from a year earlier, with the FY2025 full-year figure at $934.1 million, down 2.45% from the prior year.
- Assets Average was $906.9 million for Q2 2026 at Glaukos, up from $893.4 million in the prior quarter.
- Over five years, Assets Average peaked at $1.1 billion in Q1 2022 and troughed at $893.4 million in Q1 2026.
- A 5-year average of $966.2 million and a median of $958.7 million in 2023 frame the typical range for Assets Average.
- Across the five-year window, Assets Average grew 7.59% in 2025 and decreased 7.94% in 2026, its largest moves.
- Over 5 years, Assets Average stood at $1.0 billion in 2022, then declined by 6.06% to $944.5 million in 2023, then grew by 0.65% to $950.6 million in 2024, then slipped by 0.44% to $946.4 million in 2025, then retreated by 4.17% to $906.9 million in 2026.
- The last three Assets Average figures came in at $906.9 million (Q2 2026), $893.4 million (Q1 2026), and $946.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 178.06 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 105.21 Bn | 101.73 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 66.61 Bn | 66.07 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.47 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 21.09 Bn | 20.61 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Glaukos | 10.64 Bn | 10.52 Bn | 151.59 Mn | 906.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 906.92 Mn |
| Mar 31, 2026 | 893.41 Mn |
| Dec 31, 2025 | 946.43 Mn |
| Sep 30, 2025 | 993.17 Mn |
| Jun 30, 2025 | 976.57 Mn |
| Mar 31, 2025 | 970.47 Mn |
| Dec 31, 2024 | 950.65 Mn |
| Sep 30, 2024 | 923.11 Mn |
| Jun 30, 2024 | 926.51 Mn |
| Mar 31, 2024 | 936.88 Mn |
| Dec 31, 2023 | 944.52 Mn |
| Sep 30, 2023 | 952.69 Mn |
| Jun 30, 2023 | 964.67 Mn |
| Mar 31, 2023 | 987.49 Mn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | 1.04 Bn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 1.06 Bn |
| Sep 30, 2021 | 1.05 Bn |